Fred Reynolds

1.6k total citations
22 papers, 1.3k citations indexed

About

Fred Reynolds is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomaterials. According to data from OpenAlex, Fred Reynolds has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Biomaterials. Recurrent topics in Fred Reynolds's work include Advanced biosensing and bioanalysis techniques (7 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Fred Reynolds is often cited by papers focused on Advanced biosensing and bioanalysis techniques (7 papers), RNA Interference and Gene Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Fred Reynolds collaborates with scholars based in United States, Austria and Switzerland. Fred Reynolds's co-authors include Ralph Weissleder, Lee Josephson, Matthias Nahrendorf, Xavier Montet, Kimberly M. Kelly, Karin Montet-Abou, Eyk Schellenberger, David E. Sosnovik, Anthony Rosenzweig and Takashi Matsui and has published in prestigious journals such as Circulation, PLoS ONE and Analytical Chemistry.

In The Last Decade

Fred Reynolds

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Reynolds United States 17 534 400 380 341 183 22 1.3k
Lisa Detering United States 20 259 0.5× 449 1.1× 396 1.0× 284 0.8× 289 1.6× 35 1.2k
Anne M. Morawski United States 6 285 0.5× 350 0.9× 313 0.8× 454 1.3× 337 1.8× 8 1.2k
Thomas D. Harris United States 17 588 1.1× 357 0.9× 322 0.8× 665 2.0× 148 0.8× 42 1.8k
Evan H. Phillips United States 14 295 0.6× 660 1.6× 396 1.0× 191 0.6× 271 1.5× 28 1.2k
Hongcheng Shi China 16 226 0.4× 405 1.0× 302 0.8× 199 0.6× 145 0.8× 65 1.0k
Marina V. Backer United States 25 838 1.6× 523 1.3× 246 0.6× 605 1.8× 181 1.0× 61 1.9k
Qimeng Quan China 17 455 0.9× 476 1.2× 396 1.0× 271 0.8× 432 2.4× 24 1.5k
E Marecos United States 15 357 0.7× 283 0.7× 280 0.7× 206 0.6× 127 0.7× 19 940
Dinah Tzemach Israel 9 587 1.1× 405 1.0× 794 2.1× 121 0.4× 109 0.6× 11 1.4k
Peter A. Jarzyna United States 12 541 1.0× 516 1.3× 566 1.5× 105 0.3× 278 1.5× 17 1.3k

Countries citing papers authored by Fred Reynolds

Since Specialization
Citations

This map shows the geographic impact of Fred Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Reynolds more than expected).

Fields of papers citing papers by Fred Reynolds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Reynolds. The network helps show where Fred Reynolds may publish in the future.

Co-authorship network of co-authors of Fred Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Reynolds. A scholar is included among the top collaborators of Fred Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Reynolds. Fred Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reynolds, Fred, et al.. (2011). A Functional Proteomic Method for Biomarker Discovery. PLoS ONE. 6(7). e22471–e22471. 17 indexed citations
2.
Reynolds, Fred & Kimberly M. Kelly. (2011). Techniques for molecular imaging probe design.. PubMed. 10(6). 407–19. 18 indexed citations
3.
Reynolds, Fred & Kimberly M. Kelly. (2011). Techniques for Molecular Imaging Probe Design. Molecular Imaging. 10(6). 16 indexed citations
4.
Ronald, John A., John W. Chen, Yuanxin Chen, et al.. (2009). Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques. Circulation. 120(7). 592–599. 122 indexed citations
5.
Salthouse, Christopher, et al.. (2009). Quantitative measurement of protease activity with correction of probe delivery and tissue absorption effects. Sensors and Actuators B Chemical. 138(2). 591–597. 7 indexed citations
6.
Sosnovik, David E., Élisabeth Garanger, Elena Aïkawa, et al.. (2009). Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed-Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes In Vivo. Circulation Cardiovascular Imaging. 2(6). 460–467. 78 indexed citations
7.
Sosnovik, David E., Matthias Nahrendorf, Peter Panizzi, et al.. (2009). Molecular MRI Detects Low Levels of Cardiomyocyte Apoptosis in a Transgenic Model of Chronic Heart Failure. Circulation Cardiovascular Imaging. 2(6). 468–475. 45 indexed citations
8.
Garanger, Élisabeth, Elena Aïkawa, Fred Reynolds, Ralph Weissleder, & Lee Josephson. (2008). Simplified syntheses of complex multifunctional nanomaterials. Chemical Communications. 4792–4792. 38 indexed citations
9.
Gee, Michael S., Rabi Upadhyay, Herlen Alencar, et al.. (2008). Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/neu-targeted Therapy. Radiology. 248(3). 925–935. 52 indexed citations
10.
Montet, Xavier, Karin Montet-Abou, Fred Reynolds, Ralph Weissleder, & Lee Josephson. (2006). Nanoparticle Imaging of Integrins on Tumor Cells. Neoplasia. 8(3). 214–222. 191 indexed citations
11.
Kelly, Kimberly M., et al.. (2006). In Vivo Phage Display Selection Yields Atherosclerotic Plaque Targeted Peptides for Imaging. Molecular Imaging and Biology. 8(4). 201–207. 105 indexed citations
12.
Sosnovik, David E., Eyk Schellenberger, Matthias Nahrendorf, et al.. (2005). Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle. Magnetic Resonance in Medicine. 54(3). 718–724. 187 indexed citations
13.
Funovics, Martin, Xavier Montet, Fred Reynolds, Ralph Weissleder, & Lee Josephson. (2005). Nanoparticles for the Optical Imaging of Tumor selectin. Neoplasia. 7(10). 904–911. 58 indexed citations
14.
Reynolds, Fred, et al.. (2005). Method of Determining Nanoparticle Core Weight. Analytical Chemistry. 77(3). 814–817. 57 indexed citations
15.
Koch, Annette, Fred Reynolds, Hans P. Merkle, Ralph Weissleder, & Lee Josephson. (2005). Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers. ChemBioChem. 6(2). 337–345. 81 indexed citations
16.
Reynolds, Fred, Ralph Weissleder, & Lee Josephson. (2005). Protamine as an Efficient Membrane-Translocating Peptide. Bioconjugate Chemistry. 16(5). 1240–1245. 90 indexed citations
17.
Schellenberger, Eyk, Fred Reynolds, Ralph Weissleder, & Lee Josephson. (2004). Surface‐Functionalized Nanoparticle Library Yields Probes for Apoptotic Cells. ChemBioChem. 5(3). 275–279. 64 indexed citations
18.
Kelly, Kimberly M., Fred Reynolds, Ralph Weissleder, & Lee Josephson. (2004). Fluorescein isothiocyanate–hapten immunoassay for determination of peptide–cell interactions. Analytical Biochemistry. 330(2). 181–185. 16 indexed citations
19.
Reynolds, Fred, et al.. (2000). Correlation between Polystyrene Molecular Weight and Initiator Properties in Microemulsion Polymerization. Macromolecules. 34(2). 165–170. 7 indexed citations
20.
Reynolds, Fred, Dezider Grünberger, Josef Pitha, & Paula M. Pitha. (1972). Inhibition of cell-free protein synthesis by poly(9-vinyladenine), poly(1-vinyluracil), and the corresponding vinyl copolymer. Biochemistry. 11(17). 3261–3266. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026